GLP-1 and GIP are the hormones behind the world's most talked-about weight-loss drugs — and your gut already produces them after every meal. DPP-IV is the enzyme that switches them off almost immediately. PlantDPP is a plant-derived ingredient designed to get in its way.
The whole cycle takes minutes. Step four is the one most people have never heard of — and it's where this entire story lives.
Food arrives in your small intestine.
Specialized cells release hormones called incretins — GLP-1 and GIP.
Insulin is released, the liver slows sugar output, and the brain registers fullness.
An enzyme called DPP-IV destroys those hormones within minutes.
Made by sensor cells scattered through your gut lining, released within minutes of eating.
Dipeptidyl Peptidase-4 — the name is the job description. It snips exactly two amino acids off the end of a protein chain, wherever the second bead is alanine or proline.
GLP-1's chain — position two is alanine, so DPP-IV cuts here. Once those first two beads are gone, the hormone no longer fits its receptor. It still exists — it just stops working.
There are two very different ways to work with this system.
A laboratory-built copy of GLP-1 is injected. It's deliberately redesigned so DPP-IV can't cut it — so it lasts for days instead of minutes.
Instead of adding a copy, get in the way of DPP-IV so the hormone your body already made survives longer.
A group of tiny protein fragments — peptides — made from spirulina, shaped so DPP-IV grabs them instead of grabbing your hormones. These peptides don't exist in ordinary spirulina powder; they're created during manufacturing.
A protein-rich algae eaten as food for decades.
Long chains, folded up. Not active in this way on their own.
An enzyme snips the long chains into thousands of short fragments.
Only the smallest, most useful fragments are kept.
A dried powder standardized by how well it blocks the enzyme.
Being straight about this: everything proven to date is in test tubes and animals. Promising — but not the same as proven in people.
Spirulina peptides measurably block DPP-IV — shown by several independent research groups.
Individual active fragments have been isolated and their sequences read.
Oral dosing lowered fasting blood sugar and improved glucose tolerance in diabetic mice.
Digestion appears to improve, not destroy, the activity — encouraging for an oral product.
Not yet done — for this ingredient or any other of its type. This is the gap the planned clinical study is designed to fill.
Because the two-minute lifespan describes a single molecule, not the whole signal. Your gut keeps releasing more GLP-1 and GIP for as long as food is moving through — often an hour or two. Slowing the destruction side shifts the balance up, without making any more hormone. GLP-1 is also only one voice in the chorus: stomach stretch, PYY, CCK, dropping ghrelin, and slower stomach emptying all contribute to feeling full.
No. PlantDPP is positioned for people who are not on GLP-1 drugs, or who are transitioning off them — not as an add-on to active prescription therapy. The injectable drugs are engineered to resist DPP-IV, so slowing DPP-IV down has no effect on them.
The hormones, the nerve endings that respond to them, and most of the DPP-IV that destroys them are all concentrated in the same few square inches of gut wall. A swallowed capsule delivers its contents directly into that space — at its highest concentration, in direct contact with the enzyme — without needing to survive digestion, cross the gut wall, or circulate through the blood in meaningful amounts.
Test-tube inhibition of DPP-IV by spirulina-derived peptides, identification of the active fragments, and favorable results in oral animal studies. No human clinical study of this ingredient — or any ingredient of its type — has been completed yet. That study is the point of the plan, and everything about expected effects in people remains a hypothesis until it reads out.
The investor overview covers market opportunity, business model, capital requirements, and illustrative projections. Access requires a password provided by NewCo.